Commodore Capital Lp Buys Dicerna Pharmaceuticals Inc, IVERIC bio Inc, Merus NV, Sells , Macrogenics Inc, ESSA Pharma Inc

• New Purchases: DRNA, MRUS, TNYA, IOVA, RVMD,
• Added Positions: ISEE, ACRS, VRDN, KURA, PTGX, VTGN, COGT, XENE, CYTK, CBAY, KALV, CELC, GNCA,
• Reduced Positions: CLDX, ATXS, MREO,
• Sold Out: CNST, MGNX, EPIX, MRSN, MCRB,

For the details of COMMODORE CAPITAL LP's stock buys and sells, go to https://www.gurufocus.com/guru/commodore+capital+lp/current-portfolio/portfolio

1. IVERIC bio Inc (ISEE) - 2,750,137 shares, 11.78% of the total portfolio. Shares added by 57.31%
2. Aclaris Therapeutics Inc (ACRS) - 2,190,291 shares, 10.39% of the total portfolio. Shares added by 31.23%
3. Cytokinetics Inc (CYTK) - 796,578 shares, 7.51% of the total portfolio. Shares added by 13.10%
4. Dicerna Pharmaceuticals Inc (DRNA) - 1,292,251 shares, 6.87% of the total portfolio. New Position
5. C4 Therapeutics Inc (CCCC) - 481,094 shares, 5.67% of the total portfolio.

Commodore Capital Lp initiated holding in Dicerna Pharmaceuticals Inc. The purchase prices were between $19.68 and $39.99, with an estimated average price of $27.67. The stock is now traded at around $38.080000. The impact to a portfolio due to this purchase was 6.87%. The holding were 1,292,251 shares as of 2021-09-30.

Commodore Capital Lp initiated holding in Merus NV. The purchase prices were between $16.48 and $27.23, with an estimated average price of $21.52. The stock is now traded at around $24.980000. The impact to a portfolio due to this purchase was 4.17%. The holding were 718,136 shares as of 2021-09-30.

Commodore Capital Lp initiated holding in Tenaya Therapeutics Inc. The purchase prices were between $15.35 and $26.66, with an estimated average price of $21.56. The stock is now traded at around $18.690000. The impact to a portfolio due to this purchase was 2.8%. The holding were 513,930 shares as of 2021-09-30.

Commodore Capital Lp initiated holding in Iovance Biotherapeutics Inc. The purchase prices were between $20.35 and $26.63, with an estimated average price of $23.63. The stock is now traded at around $18.240000. The impact to a portfolio due to this purchase was 2.36%. The holding were 362,869 shares as of 2021-09-30.

Commodore Capital Lp initiated holding in Revolution Medicines Inc. The purchase prices were between $23.95 and $33.41, with an estimated average price of $29.16. The stock is now traded at around $26.700000. The impact to a portfolio due to this purchase was 1.64%. The holding were 226,228 shares as of 2021-09-30.

Commodore Capital Lp added to a holding in IVERIC bio Inc by 57.31%. The purchase prices were between $7.07 and $17.5, with an estimated average price of $10.82. The stock is now traded at around $15.040000. The impact to a portfolio due to this purchase was 4.29%. The holding were 2,750,137 shares as of 2021-09-30.

Commodore Capital Lp added to a holding in Aclaris Therapeutics Inc by 31.23%. The purchase prices were between $13.38 and $18.8, with an estimated average price of $16.07. The stock is now traded at around $12.270000. The impact to a portfolio due to this purchase was 2.47%. The holding were 2,190,291 shares as of 2021-09-30.

Commodore Capital Lp added to a holding in Viridian Therapeutics Inc by 258.18%. The purchase prices were between $10.69 and $18.2, with an estimated average price of $14.67. The stock is now traded at around $17.970000. The impact to a portfolio due to this purchase was 2.09%. The holding were 667,674 shares as of 2021-09-30.

Commodore Capital Lp added to a holding in Kura Oncology Inc by 60.81%. The purchase prices were between $15.42 and $21.72, with an estimated average price of $18.88. The stock is now traded at around $13.940000. The impact to a portfolio due to this purchase was 1.87%. The holding were 999,433 shares as of 2021-09-30.

Commodore Capital Lp added to a holding in Protagonist Therapeutics Inc by 136.50%. The purchase prices were between $12.95 and $49.69, with an estimated average price of $42.78. The stock is now traded at around $32.570000. The impact to a portfolio due to this purchase was 1.34%. The holding were 498,079 shares as of 2021-09-30.

Commodore Capital Lp added to a holding in VistaGen Therapeutics Inc by 53.80%. The purchase prices were between $2.62 and $3.45, with an estimated average price of $2.91. The stock is now traded at around $1.860000. The impact to a portfolio due to this purchase was 1.29%. The holding were 5,123,509 shares as of 2021-09-30.

Commodore Capital Lp sold out a holding in . The sale prices were between $33.9 and $33.99, with an estimated average price of $33.95.

Commodore Capital Lp sold out a holding in Macrogenics Inc. The sale prices were between $19.74 and $28.7, with an estimated average price of $24.13.

Commodore Capital Lp sold out a holding in ESSA Pharma Inc. The sale prices were between $7.76 and $29.37, with an estimated average price of $15.99.

Commodore Capital Lp sold out a holding in Mersana Therapeutics Inc. The sale prices were between $8.56 and $14.47, with an estimated average price of $11.75.

Commodore Capital Lp sold out a holding in Seres Therapeutics Inc. The sale prices were between $5.46 and $22.6, with an estimated average price of $9.91.

Commodore Capital Lp reduced to a holding in Celldex Therapeutics Inc by 23.26%. The sale prices were between $28.95 and $55.99, with an estimated average price of $46.84. The stock is now traded at around $38.720000. The impact to a portfolio due to this sale was -0.88%. Commodore Capital Lp still held 248,207 shares as of 2021-09-30.